{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:48:38Z","timestamp":1792522118059,"version":"4.5.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2023,2]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n Cardiovascular disease\u2014a key driver of morbidity in CKD\u2014is common in patients with autosomal dominant polycystic kidney disease (ADPKD).<\/jats:p>\n <\/jats:list-item>\n \n Pathologic echocardiography findings, including valvular defects, aortic root dilation, and hypertrophy, are found in most patients with ADPKD.<\/jats:p>\n <\/jats:list-item>\n \n These findings correlate with parameters indicating disease progression in ADPKD. Echocardiography should be offered to all patients with ADPKD.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n ADPKD is the most common monogenetic kidney disease and results in kidney failure in >75% of affected individuals. As a systemic disorder, ADPKD is associated with a variety of extrarenal manifestations, including cardiac manifestations, that affect the majority of patients. We characterized the cardiac involvement in patients with ADPKD from the German AD(H)PKD registry and compared them with kidney donor candidates as controls.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n In this single-center cohort study, we evaluated 141 patients with ADPKD (44.17\u00b111.23 years) from the German AD(H)PKD registry and 60 kidney donor candidates (55.08\u00b110.21 years). All patients underwent clinical examination, abdominal MRI, and transthoracic echocardiography.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of the patients with ADPKD, 65% showed hypertrophy of the left ventricle (as defined by an end-diastolic interventricular septal wall thickness [IVSd] >10 mm) compared with 55% in control patients. Mitral regurgitation was the most common finding among 54% of patients with ADPKD who exhibited valvular dysfunction, albeit mild in most patients. Interestingly, left ventricular ejection fraction (LV-EF) differed significantly between both groups, with higher values in patients with ADPKD (64%\u00b16% versus 60%\u00b16%), whereas other parameters, including IVSd, left ventricular end-diastolic diameter (LVEDD), tricuspid annular plane systolic excursion (TAPSE), and pressure gradients across the aortic and tricuspid valve were similar between groups. Correlations of echocardiographic parameters with markers of disease progression revealed statistically significant associations for aortic root diameter (\n P<\/jats:italic>\n =0.01), the pressure gradient across the aortic valve (AV dP\n max<\/jats:sub>\n ;\n P<\/jats:italic>\n =0.0003), and IVSd (\n P<\/jats:italic>\n =0.0001), indicating rapid kidney disease progression may also be associated with cardiac findings.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Cardiovascular abnormalities are prevalent in patients with ADPKD. Considering the importance of cardiovascular disease for outcomes in CKD, early management and possibly prevention are important goals of any treatment scheme. Consequently, echocardiography should be offered to all patients with ADPKD in routine management.<\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0002942022","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T18:35:13Z","timestamp":1666118113000},"page":"150-161","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Cardiac Manifestations in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single-Center Study"],"prefix":"10.34067","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-4614","authenticated-orcid":false,"given":"Sita","family":"Arjune","sequence":"first","affiliation":[{"name":"Department II of Internal Medicine and Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"},{"name":"Center for Rare Diseases Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5766-7477","authenticated-orcid":false,"given":"Franziska","family":"Grundmann","sequence":"additional","affiliation":[{"name":"Department II of Internal Medicine and Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4728-224X","authenticated-orcid":false,"given":"Polina","family":"Todorova","sequence":"additional","affiliation":[{"name":"Department II of Internal Medicine and Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hendrix","sequence":"additional","affiliation":[{"name":"Department II of Internal Medicine and Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4358-5008","authenticated-orcid":false,"given":"Roman","family":"Pfister","sequence":"additional","affiliation":[{"name":"Department III of Internal Medicine, Heart Center of the University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-3549","authenticated-orcid":false,"given":"Henrik","family":"ten Freyhaus","sequence":"additional","affiliation":[{"name":"CECAD, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6910-0745","authenticated-orcid":false,"given":"Roman-Ulrich","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department II of Internal Medicine and Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"},{"name":"Center for Rare Diseases Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"},{"name":"CECAD, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"key":"B1-20250823","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): Executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"key":"B2-20250823","article-title":"Cystic kidney diseases from the adult nephrologist\u2019s point of view","author":"M\u00fcller","journal-title":"Front Pediatr"},{"key":"B3-20250823","article-title":"Autosomal dominant polycystic kidney disease","author":"Torres","journal-title":"Lancet"},{"key":"B4-20250823","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfs551","article-title":"Epidemiology of autosomal-dominant polycystic kidney disease: An in-depth clinical study for south-western Germany","volume":"28","author":"Neumann","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B5-20250823","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/jcm9010146","article-title":"Prediction of renal prognosis in patients with autosomal dominant polycystic kidney disease using PKD1\/PKD2 mutations","volume":"9","author":"Kataoka","year":"2020","journal-title":"J Clin Med"},{"key":"B6-20250823","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000343281","article-title":"Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease","volume":"36","author":"Helal","year":"2012","journal-title":"Am J Nephrol"},{"key":"B7-20250823","first-page":"653","article-title":"Pathogenesis of hypertension in autosomal dominant polycystic kidney disease","volume":"11","author":"Chapman","year":"1991","journal-title":"Semin Nephrol"},{"key":"B8-20250823","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"},{"key":"B9-20250823","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1681\/ASN.2008080882","article-title":"Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease","volume":"20","author":"Schrier","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B10-20250823","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1681\/ASN.V121194","article-title":"Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects","volume":"12","author":"Ecder","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B11-20250823","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","article-title":"Left ventricular hypertrophy in autosomal dominant polycystic kidney disease","volume":"8","author":"Chapman","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"B12-20250823","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijcard.2018.10.063","article-title":"Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trial","volume":"275","author":"Spinelli","year":"2019","journal-title":"Int J Cardiol"},{"key":"B13-20250823","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.2215\/CJN.04610511","article-title":"Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease","volume":"6","author":"Perrone","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B14-20250823","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/ckj\/sfy103","article-title":"Management of autosomal-dominant polycystic kidney disease-state-of-the-art","volume":"11","author":"M\u00fcller","year":"2018","journal-title":"Clin Kidney J"},{"key":"B15-20250823","article-title":"Autosomal dominant polycystic kidney patients may be predisposed to various cardiomyopathies","author":"Chebib","journal-title":"Kidney Int Rep"},{"key":"B16-20250823","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/ajkd.2001.29216","article-title":"Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1","volume":"38","author":"Lumiaho","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"B17-20250823","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1681\/ASN.V3188","article-title":"Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease","volume":"3","author":"Schievink","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"B18-20250823","article-title":"Increased occurrence of pericardial effusion in patients with autosomal dominant polycystic kidney disease","author":"Qian","journal-title":"Clin J Am Soc Nephrol"},{"key":"B19-20250823","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: A simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B20-20250823","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: Recommendations from the American Society of Echocardiography","author":"Mitchell","journal-title":"J Am Soc Echocardiogr"},{"key":"B21-20250823","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"B22-20250823","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.amjcard.2012.05.063","article-title":"Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons \u226515 years of age","volume":"110","author":"Devereux","year":"2012","journal-title":"Am J Cardiol"},{"key":"B23-20250823","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"B24-20250823","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000013583","article-title":"Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: Influence of blood pressure and humoral and neurohormonal factors","volume":"20","author":"Martinez-Vea","year":"2000","journal-title":"Am J Nephrol"},{"key":"B25-20250823","article-title":"Polycystins, ADPKD, and cardiovascular disease","author":"Kuo","journal-title":"Kidney Int Rep"},{"key":"B26-20250823","article-title":"Echocardiographic findings in autosomal dominant polycystic kidney disease","author":"Hossack","journal-title":"N Engl J Med"},{"key":"B27-20250823","article-title":"The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: A 10-year follow-up in a five-generation kindred","author":"Timio","journal-title":"Clin Nephrol"},{"key":"B28-20250823","article-title":"Cardiovascular abnormalities associated with adult polycystic kidney disease","author":"Leier","journal-title":"Ann Intern Med"},{"key":"B29-20250823","first-page":"825","article-title":"[Valvular prolapse in autosomal dominant polycystic kidney [in Italian]","volume":"22","author":"Varnero","year":"1992","journal-title":"G Ital Cardiol"},{"key":"B30-20250823","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000424416","article-title":"Cardiac valvular abnormalities in ADPKD. Preliminary results from the Italian Multicentric Study","volume":"115","author":"Castiglioni","year":"1995","journal-title":"Contrib Nephrol"},{"key":"B31-20250823","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1111\/j.1523-1755.2005.00682.x","article-title":"Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease","volume":"68","author":"Oflaz","year":"2005","journal-title":"Kidney Int"},{"key":"B32-20250823","article-title":"Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner","author":"Pietrzak-Nowacka","journal-title":"Kidney Blood Press Res"},{"key":"B33-20250823","article-title":"Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy","author":"Paavola","journal-title":"J Mol Cell Cardiol"},{"key":"B34-20250823","article-title":"Polaris and polycystin-2 in dorsal forerunner cells and Kupffer\u2019s vesicle are required for specification of the zebrafish left-right axis","author":"Bisgrove","journal-title":"Dev Biol"},{"key":"B35-20250823","article-title":"Polycystin-1 is a cardiomyocyte mechanosensor that governs L-type Ca2+ channel protein stability","author":"Pedrozo","journal-title":"Circulation"},{"key":"B36-20250823","article-title":"Arrhythmogenic hearts in PKD2 mutant mice are characterized by cardiac fibrosis, systolic, and diastolic dysfunctions","author":"Amirrad","journal-title":"Front Cardiovasc Med"},{"key":"B37-20250823","article-title":"Caution regarding the use of pilot studies to guide power calculations for study proposals","author":"Kraemer","journal-title":"Arch Gen Psychiatry"},{"key":"B38-20250823","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1592\/phco.21.5.405.34503","article-title":"Post hoc power analysis: An idea whose time has passed?","volume":"21","author":"Levine","year":"2001","journal-title":"Pharmacotherapy"},{"key":"B39-20250823","doi-asserted-by":"crossref","first-page":"e100069","DOI":"10.1136\/gpsych-2019-100069","article-title":"Post hoc power analysis: Is it an informative and meaningful analysis?","volume":"32","author":"Zhang","year":"2019","journal-title":"Gen Psychiatr"}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0002942022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:59:54Z","timestamp":1786478394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0002942022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0002942022","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]},"assertion":[{"value":"2022-04-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}